IMC Ethiopia Baseline Mental Health Situational Analysis Dollo Ado ...
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa...
-
Upload
silvia-summers -
Category
Documents
-
view
214 -
download
1
Transcript of The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa...
1
The Pharmaceutical Situational Analysis in
Mongolia
Chimedtseren Munkhdelger1 Sanjjav Tsetsegmaa2,
1Ministry of Health, 2Pharmacy School, Health Sciences
University
Third International Conference For Improving Use of Medicines, November 14-18, 2011, Antalya, Turkey
2
Background• General information about Mongolia
– territory: 1.564,116 km2 – population: 2.78 million – provinces: 21( which are divided
into 329 counties) – capital city: Ulaanbaatar (9 districts)
• The National Medicine Policy of Mongolia (NMPM) was approved by the Parliament in 2002.
• The Law on Drugs and Medical Devices (1998) was amended twice and was revised by the Parliament in 2010.
• The EML was initially approved in 1991. Since then it has been revised every four years.
• 2nd Pharmaceutical Sector Assessment was conducted in 2004.
3
Purpose of the study
Identify strengths and weaknesses in the pharmaceutical sector of Mongolia and develop recommendations for future improvements and possible interventions.
4
Methods
• “WHO Operational package for assessing, monitoring and evaluating country pharmaceutical situations: Guide for coordinators and data collectors” was used.
• The study was conducted in 5 geographical areas and the capital city.
• The key medicines were chosen based on the disease pattern in Mongolia and several discussions held with health professionals.
5
Methods: Selecting the geographical areas & sampling
Selected the geographical
areas
Number of Sampled facilities Number of
sampled patients
Public health
facilities
Private pharmacy
Whole saler
Ulaanbaatar 5 5 1 30Western region 5 5 1 30
Eastern region 5 5 1 30Gobi region 5 5 1 30Mountain region
5 5 1 30
Central region 5 5 1 30
6
Results: Availability of key medicines (%)
Public
hea
lth fa
cilitie
s
Pivate
pha
rmac
ies
War
ehou
ses
Count
ry a
vera
ge
0102030405060708090 80 86.75 88.7
85.13
64.52
2009
2004
7
Results: Affordability of treating moderate pneumonia (daily wage)
Public facility Private facility 0
0.20.40.60.8
11.21.41.61.8
1.71.8
0.9 0.9 Affordability of treatment for adultsAffordabilty of treatment children under 5 years of age
Cost of treating moderate pneumonia Affordability= ------------------------------------------------------ Lowest daily salary of unskilled government worker
8
Results: Geographical accessibility to facilities
Public health facilities Private pharmacy0
1
2
3
4
5
6
7 6.7%
3.3%
9
Rational use of medicine• The percentage of antibiotics per encounter increased
from 15% to 46.7% since the last assessment. • The average percentage of injections per encounter
decreased from 12% in 2004 to 6.70% in 2009. • The percentage of medicines prescribed by generic
name in public health facilities was 68.7% on average.
Quality• The best result for adequate conservation condition
and handling in storage rooms was observed in wholesaling companies (86%) followed by retail pharmacies (81.8%) and least in public health facilities (72.7%).
Results:
10
Policy implications To improve the accessibility and availability of essential medicines:• Advance the medicine supply management skills of
health personnels at various levels,• Develop the medicine pricing policy and enhance the
transparency in it’s implementation procedures.
To improve medicine quality:• Improve the storage conditions of medicines in public
health facilities,• Ensure that the local manufacturers comply with GMP
requirements with proper certification,• Establish PMS for registered medicines.
11
Policy implications
To improve rational use of medicine: • Improve the prescribing and dispensing practices by
organizing trainings and educational programs, i.e. rational medicine use with support of the Government,
• Investigate and develop interventions for the misuse of antibiotics to further decrease the number of patients receiving antibiotics.